Analytical Data
-
Gene name
BMP-3
- Application
-
Alternative Names
Bone morphogenetic protein 3A ;BMP-3AOsteogenin
-
Species
Human
-
Source
E. coli
-
Tag
C- Myc
-
Purity
Greater than 85% as determined by SDS-PAGE.
-
Uniprot
P12645
-
Expression Region
363-472aa
-
Protein Length
Partial
-
Molecular Weight
13.9 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
The study of BMP-3 recombinant protein is rooted in its critical role as a member of the Bone Morphogenetic Protein (BMP) family, which is essential for various biological processes, including bone and cartilage development, cellular differentiation, and homeostasis. BMP-3 is particularly notable for its function as a negative regulator of bone formation, distinguishing it from other BMPs that primarily promote osteogenesis. This regulatory role makes BMP-3 a significant focus in the fields of orthopedics and regenerative medicine, as it can influence therapeutic strategies for bone-related conditions and disorders, including osteoporosis and fracture healing. Researchers are increasingly interested in BMP-3 recombinant proteins due to their potential applications in bioengineering and tissue regeneration. By producing BMP-3 through recombinant techniques, scientists aim to explore its structure-function relationship, optimize its biological activity, and develop novel treatments that can modulate its effects on bone metabolism. Understanding and harnessing BMP-3's properties could lead to innovative approaches in stimulating bone repair, enhancing implant integration, and creating more effective biomaterials in clinical settings.
